Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy

Bone

Volumn 34, Issue 1, 2004, Pages 216-224

  Ng, A H M ^a,b   Hercz, G ^b,c   Kandel, R ^a,b   Grynpas, M D ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HUMBER RIVER REGIONAL HOSPITAL   (Canada)

Author keywords

Bone mineralization; Fluoride; Magnesium; PTH; Renal osteodystrophy

Indexed keywords

ALUMINUM; FLUORIDE; MAGNESIUM; PARATHYROID HORMONE; TRACE ELEMENT;

ADULT; AGED; ARTICLE; ASSOCIATION; BIOMECHANICS; BONE BIOPSY; BONE MARROW BIOPSY; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; CHEMICAL COMPOSITION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSIS; DISEASE COURSE; FEMALE; HARDNESS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINERALIZATION; QUALITY CONTROL; RENAL OSTEODYSTROPHY;

EID: 0742289168     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2003.08.006     Document Type: Article

References (47)

1. Bellorin-Font E., Weaver M.E., Stokes T.J. Jr., McConkey C. Jr., Slatopolsky E., Martin K.J. Effects of aluminum on bovine parathyroid adenylate cyclase. Endocrinology. 117:1985;1456-1461.
2. Boivin G., Chavassieux P., Chapuy M.C., Baud C.A., Meunier P.J. Profil histomorphométrique de la fluorose osseuse induite par l'ingestion prolongée d'eau de Vichy Saint-Yorre. Comparaison avec le taux de fluor osseux. Pathol. Biol. 34:1986;33-39.
3. Boivin G., Chavassieux P., Chapuy M.C., Baud C.A., Meunier P.J. Skeletal fluorosis: histomorphometric findings. J. Bone Miner. Res. (Suppl. 1):1990;S185-S189.
4. Bracci P.M., Bull S.B., Grynpas M.D. Analysis of compositional bone density data using log ratio transformations. Biometrics. 54:1988;337-349.
5. Brilla L.R., Fredrickson J.H., Lombardi V.P. Effect of hypomagnesemia and exercise on slowly exchanging pools of magnesium. Metabolism. 38:1989;797-800.
6. Charen J., Taves D.R., Stamm J.W., Parkins F.M. Bone fluoride concentrations associated with fluoridated drinking water. Calcif. Tissue Int. 27:1979;95-99.
7. Christoffersen M.E., Christoffersen J. The effect of aluminum on the rate of dissolution of calcium hydroxyapatite - a contribution to the understanding of aluminum-induced bone diseases. Calcif. Tissue Int. 37:1985;673-676.
8. Coco M., Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am. J. Kidney Dis. 36:2000;1115-1121.
9. Currey J.D. Effects of differences in mineralization on the mechanical properties of bone. Philos. Trans. R. Soc. Lond. B Biol. Sci. 304:1984;509-518.
10. Currey J.D. Physical characteristics affecting the tensile failure properties of compact bone. J. Biomech. 23:1990;837-844.
11. Denton J., Freemont A.J., Ball J. Detection and distribution of aluminium in bone. J. Clin. Pathol. 37:1984;136-142.
12. Dunstan C.R., Evans R.A., Hills E., Wong S.Y., Alfrey A.C. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure. Calcif. Tissue Int. 36:1984;133-138.
13. Garrahan N.J., Mellish R.W., Compston J.E. A new method for the two-dimensional analysis of bone structure in human iliac crest biopsies. J. Microsc. 142:1986;341-349.
14. Gerster J.C., Charhon S.A., Jaeger P., Boivin G., Briancon D., Rostan A.et al. Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis. Br. Med. J. (Clin. Res. Ed.). 287:1983;723-725.
15. Gonella M., Ballanti P., DellaRocca C., Calabrese G., Pratesi G., Vagelli G.et al. Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients. Miner. Electrolyte Metab. 13:1988;240-245.
16. Grynpas M.D., Hancock R.G., Greenwood C., Turnquist J., Kessler M.J. The effects of diet, age, and sex on the mineral content of primate bones. Calcif. Tissue Int. 52:1993;399-405.
17. Helliwell T.R., Kelly S.A., Walsh H.P., Klenerman L., Haines J., Clark R.et al. Elemental analysis of femoral bone from patients with fractured neck of femur or osteoarthrosis. Bone. 18:1996;151-157.
18. Heydorn K. Neutron activation analysis for clinical trace element research. vol. 1:1984;73-83 CRC Press, Boca Raton, FL.
19. Hercz G., Pei Y., Greenwood C., Manuel A., Saiphoo C., Goodman W.G.et al. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int. 44:1993;860-866.
20. Institute of Medicine. Food and Nutrition Board Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D and fluoride. 1999;National Academy Press, Washington, DC, USA.
21. Kausz A.T., Antonsen J.E., Hercz G., Pei Y., Weiss N.S., Emerson S.et al. Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients. Am. J. Kidney Dis. 34:1999;688-693.
22. Lappalainen R., Knuuttila M., Lammi S., Alhava E.M. Fluoride content related to the elemental composition, mineral density and strength of bone in healthy and chronically diseased persons. J. Chronic Dis. 36:1983;707-713.
23. Lappalainen R., Knuuttila M. Mg content of healthy and chronically diseased human cancellous bone in relation to age and some physical and chemical factors. Med. Biol. 63:1985;144-148.
24. Morrissey J., Rothstein M., Mayer G., Slatopolsky E. Suppression of parathyroid hormone by aluminum. Kidney Int. 23:1983;699.
25. Navarro J.F., Macia M.L., Gallego E., Mendez M.L., Chahin J., Garcia-Nieto V.et al. Serum magnesium concentration and PTH levels. Is long term chronic hypermagnesemia a risk for adynamic bone disease? Scand. J. Urol. Nephrol. 31:1997;275-280.
26. Navarro J.F., Mora C., Jimenez A., Torres A., Macia M., Garcia J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am. J. Kidney Dis. 34:1999;43-48.
27. Navarro J.F., Mora C., Macia M., Garcia J. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit. Dial. Int. 19:1999;455-461.
28. Noel C., Gosselin B., Dracon M., Pagniez D., Lemaguer D., Lemaitre L.et al. Risk of bone disease as a result of fluoride intake in chronic renal insufficiency. Nephrologie. 6:1985;181-185.
29. Nussbaum S.R., Zahradnik F.J., Labigne J.R., Brennen G.L., Nozeweung K., Kim L.Y. Highly sensitive two-site immunoradiometric assay of parathyroid hormone and its clinical utility in evaluating patients with hypercalcemia. Clin. Chem. 33:1987;1364-1367.
30. Orcel P., de Vernejoul M.C., Prier A., Miravet L., Kuntz D., Kaplan G. Stress fractures of the lower limbs in osteoporotic patients treated with fluoride. J. Bone Miner. Res. (Suppl. 1):1990;S191-S194.
31. Parfitt A., Florieux F., Kanis J., Malluche H., Meunier P., Ott S.et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J. Bone Miner. Res. 10:1987;149-156.
32. Parkins F.M., Tinanoff N., Moutinho M., Anstey M.B., Waziri M.H. Relationships of human plasma fluoride and bone fluoride to age. Calcif. Tissue Res. 16:1974;335-338.
33. Pei Y., Hercz G., Greenwood C., Sherrard D., Segre G., Manuel A.et al. Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. Kidney Int. 41:1992;1374-1382.
34. Pei Y., Hercz G., Greenwood C., Segre G., Manuel A., Saiphoo C.et al. Renal osteodystrophy in diabetic patients. Kidney Int. 44:1993;159-164.
35. Pei Y., Hercz G., Greenwood C., Segre G., Manuel A., Saiphoo C.et al. Risk factors for renal osteodystrophy: a multivariant analysis. J. Bone Miner. Res. 10:1995;149-156.
36. Posner A.S., Blumenthal N.C., Boskey A.L. Model of aluminum-induced osteomalacia: inhibition of apatite formation and growth. Kidney Int. 1986;S17-S19. Suppl. Feb.
37. Richards A., Mosekilde L., Søgaard C.H. Normal age-related changes in fluoride content of vertebral trabecular bone-relation to bone quality. Bone. 15:1994;21-26.
38. Rodriguez M., Felsenfeld A.J., Llach F. The evolution of osteomalacia in the rat with acute aluminum toxicity. J. Bone Miner. Res. 4:1989;687-696.
39. Schenk R.K., Olah A.J., Herrmann W. Preparation of calcified tissues for light microscopy. Dickson G.R. Methods of calcified tissue preparation. 1984;1-77 Elsevier Science, Amsterdam.
40. Serra J. Image analysis and mathematical morphology. 1982;Academic Press, London.
41. Sherrard D.J., Hercz G., Pei Y., Maloney N.A., Greenwood C., Manuel A.et al. The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int. 43:1993;436-442.
42. Sherrard D.J., Hercz G., Pei Y., Segre G. The aplastic form of renal osteodystrophy. Nephrol. Dial. Transplant. 11(Suppl. 3):1996;29-31.
43. Singer L., Ophaug R.H., Harland B.F. Dietary fluoride intake of 15-19-year-old male adults residing in the United States. J. Dent. Res. 64:1985;1302-1305.
44. Stein I.D., Granik G. Human vertebral bone: relation of strength, porosity, and mineralization to fluoride content. Calcif. Tissue Int. 32:1980;189-194.
45. Turner C.H. Biomechanics of bone: determination of skeletal fragility and bone quality. Osteoporos. Int. 13:2002;97-104.
46. Turner C.H., Owan I., Brizendien E.J., Zhang W., Wilson M.E., Dunipace A.J. High fluoride intakes cause osteomalacia and diminished bone strength in rats with renal deficiency. Bone. 19:1996;595-601.
47. Vesterby A., Gundersen H.J.G., Melson F. Star volume of marrow space and trabeculae of the first lumbar vertebra: sampling efficiency and biological variation. Bone. 10:1989;7-13.